News
-
Advocates Tour Alberta to Stop Plasma Privatization
Advocates Tour Alberta to Stop Plasma Privatization
Friends of Medicare are partnering with BloodWatch.org advocate Kat Lanteigne and touring Alberta September 12 – 16 to campaign in support of voluntary plasma collection and against the private for-profit plasma lobby.
-
Accountability and Transparency Needed for Long-Term Care Operators
Accountability and Transparency Needed for Long-Term Care Operators
Friends of Medicare are calling for accountability and transparency for private for-profit operators like Park Place Seniors Living in light of today’s announcement from Alberta Health that they will be opening 99 beds in Edmonton’s Villa Marguerite.
-
Beds Remaining Open but Data Lacking in Sundre Long-Term Care Compromise
Beds Remaining Open but Data Lacking in Sundre Long-Term Care Compromise
Friends of Medicare are relieved to see 5 long-term care beds remain open at the Sundre Hospital as reported in the Sundre Round-Up, but justification for closing the other 10 beds lacks proper data. -
Kenney's Health Care Record Demands Answers
Kenney's Health Care Record Demands Answers
Friends of Medicare are calling on Jason Kenney and all future contenders in the PC Leadership race to be clear with Albertans on health care.
Despite a long record in politics and on health care Kenney did not talk about health care or where he stands on private or public care in his lengthy campaign launch on July 6. -
Action Needed for Accountable and Transparent Primary Care Networks
Action Needed for Accountable and Transparent Primary Care Networks
Friends of Medicare are pleased to see the review made public today by the Ministry of Health. Having long called for a review of Alberta's Primary Care Networks, Friends of Medicare are now calling for follow through to address the issues raised. The review found "instances where the PCN Administrative Leads were receiving remuneration that was higher than the guidelines provided", "the appropriateness of PCN spending for physician compensation was not clear," and "instances where PCNs were using public dollars on expenditures that were inappropriate".
-
Momentum for #nopaidplasma
Momentum for #nopaidplasma
Last week our Executive Director Sandra Azocar was in Winnipeg to present to the Board of Directors of Canadian Blood Services. She urged for action to support our voluntary blood and plasma collection while saying no to paid plasma.
You can read the text of Sandra's submission here.
-
Private Health Care Not There for Albertans During Downturn
Private Health Care Not There for Albertans During Downturn
Friends of Medicare are renewing their call for an audit of all private boutique clinics in Alberta in light of reports from CBC news of Calgary's Copeman clinic "discouraging patients who can't pay special fees from seeing their (Copeman's) doctors."
-
Copeman Corporate Welfare Unacceptable
Copeman Corporate Welfare Unacceptable
Following today's CBC story on the Copeman clinic Friends of Medicare are calling on the Provincial and Federal Governments to take responsibility for protecting the interests of patients and our public health care system. The story highlighted instances of both patients and Alberta Health Services paying for services, with additional strain on our public purse through tax deductions for Copeman patients.
-
Lab Report Confirms Lack of Evidence to Support Privatization
Lab Report Confirms Lack of Evidence to Support Privatization
Friends of Medicare are encouraged by today's release of the Health Quality Council of Alberta
report confirming a lack of evidence was gathered to support the privatization of Edmonton and Northern Alberta lab services. -
TPP the Wrong Prescription for a Healthy Democracy
TPP the Wrong Prescription for a Healthy Democracy
Friends of Medicare are speaking out on the potential harm the Trans Pacific Partnership trade agreement will cause to Canada’s health system.
At House of Commons consultations in Calgary, Executive Director Sandra Azocar made the case that the TPP “limits Canadians ability to find democratic and public solutions to ongoing healthcare issues, most notably on pharmaceutical costs.”